Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus 0.03% ointment versus mometasone ointment for pediatric atopic dermatitis
IRCT20091012002581N6Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Dec 2019
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in atopic dermatitis (AD) comparing Tacrolimus 0.03% ointment with Mometasone ointment (2 arms). Primary endpoints: Atopic dermatitis lesion severity index, Size of atopic dermatitis lesions and 2 more. Started Dec 2019; status: completed.
02
Drugs
tacrolimusmometasone
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on IRCT20091012002581N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20091012002581N6.